110 related articles for article (PubMed ID: 11226405)
1. Influence of phenobarbital on changes in Na(+) handling, hemodynamics and liver function due to partial portal vein ligation in rats.
Sabra R; Shuman S
Eur J Pharmacol; 2001 Feb; 413(2-3):287-94. PubMed ID: 11226405
[TBL] [Abstract][Full Text] [Related]
2. Sodium retention and hepatic function following partial portal vein ligation in the rat.
Ohno T; Branch RA; Sabra R
J Hepatol; 1993 Jun; 18(2):235-43. PubMed ID: 8409339
[TBL] [Abstract][Full Text] [Related]
3. Phenobarbital influences the development of sodium retention in liver disease induced by bile duct ligation in the rat.
Wensing G; Branch RA
Hepatology; 1990 May; 11(5):773-8. PubMed ID: 2347552
[TBL] [Abstract][Full Text] [Related]
4. Reduced liver function is the trigger for renal sodium retention following portal vein ligation in the rat.
Murakami S; Ohno T; Bernardo JF; Pfeifer CA; Li T; Zhang Y; Dubey RK; Branch RA; Sabra R
J Gastroenterol Hepatol; 1996 Sep; 11(9):850-6. PubMed ID: 8889965
[TBL] [Abstract][Full Text] [Related]
5. Adenosine does not mediate renal sodium retention and peripheral vasodilation elicited by partial portal vein ligation in rats.
Murakami S; Bernardo JF; Branch RA; Sabra R
Hepatology; 1996 Feb; 23(2):346-52. PubMed ID: 8591862
[TBL] [Abstract][Full Text] [Related]
6. Relationship between oxidative hepatic metabolism, urinary sodium excretion and sympathetic nerve activity in experimental cirrhosis in the rat.
Wensing G; Sabra R; Branch RA
Z Gastroenterol; 1995 Jan; 33(1):1-4. PubMed ID: 7886979
[TBL] [Abstract][Full Text] [Related]
7. Portal vein ligation selectively lowers hepatic cytochrome P450 levels in rats.
Farrell GC; Zaluzny L
Gastroenterology; 1983 Aug; 85(2):275-82. PubMed ID: 6862153
[TBL] [Abstract][Full Text] [Related]
8. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Oberti F; Pilette C; Rifflet H; Maïga MY; Moreau A; Gallois Y; Girault A; le Bouil A; Le Jeune JJ; Saumet JL; Feldmann G; Calès P
J Hepatol; 1997 Jun; 26(6):1363-71. PubMed ID: 9210625
[TBL] [Abstract][Full Text] [Related]
9. Renal and systemic hemodynamics in experimental cirrhosis in rats: relation to hepatic function.
Wensing G; Sabra R; Branch RA
Hepatology; 1990 Jul; 12(1):13-9. PubMed ID: 2197209
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide does not contribute to sodium retention and peripheral vasodilation induced by partial portal vein ligation in rats.
Murakami S; Bernardo JF; Jacob TD; Branch RA; Sabra R
Ren Physiol Biochem; 1995; 18(4):198-208. PubMed ID: 7481071
[TBL] [Abstract][Full Text] [Related]
11. Vascular hyporeactivity persists despite increased contractility after long-term administration of isosorbide dinitrate in portal hypertensive rats.
Huang YT; Lin HC; Tsai JF; Hou MC; Lee SD; Hong CY
J Hepatol; 1998 Jun; 28(6):1037-44. PubMed ID: 9672181
[TBL] [Abstract][Full Text] [Related]
12. [The effect of partial hepatectomy and portal vein occlusion on aminopyrine metabolism capacity of the liver in rats].
Li B; Qin Y; Saliez A; Lambott L
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):200-3. PubMed ID: 10684016
[TBL] [Abstract][Full Text] [Related]
13. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
[TBL] [Abstract][Full Text] [Related]
15. The role of central blood volume in the development of sodium retention in portal hypertensive rats.
Colombato LA; Albillos A; Groszmann RJ
Gastroenterology; 1996 Jan; 110(1):193-8. PubMed ID: 8536856
[TBL] [Abstract][Full Text] [Related]
16. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
17. Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats.
Ackerman Z; Karmeli F; Amir G; Rachmilewitz D
J Hepatol; 1996 Apr; 24(4):478-86. PubMed ID: 8738735
[TBL] [Abstract][Full Text] [Related]
18. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic administration of sildenafil on sodium retention and on the hemodynamic complications associated with liver cirrhosis in the rat.
Ghali-Ghoul R; Tahseldar-Roumieh R; Sabra R
Eur J Pharmacol; 2007 Oct; 572(1):49-56. PubMed ID: 17610866
[TBL] [Abstract][Full Text] [Related]
20. Effect of neonatal capsaicin treatment on haemodynamics and renal function in cirrhotic rats.
Li Y; Song D; Zhang Y; Lee SS
Gut; 2003 Feb; 52(2):293-9. PubMed ID: 12524416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
